Finnrick, an independent testing programme, publishes 31 assays for NextechLabs: 22 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 9 did not. Most recent assay 23 Apr 2026.
NextechLabs operates from US, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/nextechlabs.
Finnrick-tested with mixed results. Tested across 6 peptide products with 31 total samples.
NextechLabs is listed as inactive — its storefront did not respond when the liveness check last ran. Finnrick Grade C. Finnrick avg score: 7/10 across 31 samples (6 products). Mixed quality — some products test well, others below average. domain no longer exists (no NS or SOA) (checked 2026-08-10).
NextechLabs holds independent lab grade C, assigned across 31 graded samples, average score 7/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for NextechLabs, and its storefront did not respond when we last tried to read it. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 8 | 8 passed, 0 failed |
| BPC-157 | 7 | 2 passed, 5 failed |
| Tirzepatide | 6 | 4 passed, 2 failed |
| CJC-1295 | 4 | 2 passed, 2 failed |
| Ipamorelin | 4 | 4 passed, 0 failed |
| Semaglutide | 2 | 2 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Inactive — storefront unreachable |
|---|---|
| Independent lab grade | C (31 samples) |
| Average grader score | 7/10 |
| Vendor type | Research-use supplier |
NextechLabs is listed as inactive and we hold 31 Finnrick assays (22 passing, 9 failing its purity threshold); an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 31 assays for NextechLabs: 22 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 9 did not. Most recent assay 23 Apr 2026.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides, Qing Li Peptide.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: NextGen Health Peptides Review, NextGen Peptides Research Review, Nexus Bio Life Peptides Review.